Bufab AB (publ)
F:29B0

Watchlist Manager
Bufab AB (publ) Logo
Bufab AB (publ)
F:29B0
Watchlist
Price: 11.64 EUR -0.51% Market Closed
Market Cap: €2.2B

Wall St Price Targets

29B0 Price Targets Summary
Bufab AB (publ)

Wall Street analysts forecast 29B0 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 29B0 is 8.85 EUR with a low forecast of 8.3 EUR and a high forecast of 9.42 EUR.

Lowest Forecast
Price Target
8.3 EUR
29% Downside
Average Forecast
Price Target
8.85 EUR
24% Downside
Highest Forecast
Price Target
9.42 EUR
19% Downside
Bufab AB (publ) Competitors:
Price Targets
DRMA
Dermata Therapeutics Inc
160% Upside
RM
Regional Management Corp
34% Upside
ZIN
Zinc Media Group PLC
166% Upside
FRT
Federal Realty Investment Trust
13% Upside

Revenue
Forecast

11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 8%.

Gross Profit
Forecast

12% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
12% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 9%.

Operating Income
Forecast

16% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
16% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 17%.

Pre-Tax Income
Forecast

24% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
24% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 24%. The projected CAGR for the next 3 years is 15%.

Net Income
Forecast

27% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
27% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 29B0's stock price target?
Price Target
8.85 EUR

According to Wall Street analysts, the average 1-year price target for 29B0 is 8.85 EUR with a low forecast of 8.3 EUR and a high forecast of 9.42 EUR.

What is the Revenue forecast for Bufab AB (publ)?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for Bufab AB (publ)?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Bufab AB (publ)?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 17%.

What is the Pre-Tax Income forecast for Bufab AB (publ)?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 24%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Bufab AB (publ)?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett